Active-ingredient Dossier
Eplerenone
Active-ingredient Dossier for Eplerenone (aldosterone antagonist). Australian brands, products, PBS listings, PBAC outcomes — compiled by arcimedes.
- Brand: INPLER
- Brand: INSPRA
- Brand: APO-EPLERENONE
- Brand: ESPLER
- Brand: EPLERENONE
- Brand: EPLERENONE-DWRN
- Therapeutic area: Cardiology
What is
Eplerenone Eplerenone is an aldosterone antagonist.
Australian brands containing
Eplerenone — INPLER — INSPRA — APO-EPLERENONE — ESPLER — EPLERENONE — EPLERENONE-DWRN — EPLERENONE-RJIC — INPLERONE
Therapeutic areas
Eplerenone is registered in cardiology, with 8 brands containing the ingredient.
Sponsor landscape
Eplerenone is marketed by two sponsors: Arrotex Pharmaceuticals and Viatris.
PBS and regulatory activity
One brand containing eplerenone is listed on the PBS, with the latest PBS schedule date of 1 May 2026. The latest PBAC outcome was recorded on 1 December 2025, and the latest AusPAR was published on 23 May 2013.